One couple’s recipe for PD success After experiencing rigidness and fatigue, Lynda was diagnosed with...see more Parkinson’s disease (PD) at the age of 54. Like many people in her position, she was in denial at first. Fortunately, her husband of 22 years, Michael, was not only there to be her solid support […]

Read More

The results of a new study show that the incidence of Parkinson’s disease (PD), or the number of new...see more cases diagnosed per year, is 50% higher than previously estimated. Instead of past estimates of 60,000 new cases of PD diagnosed per year, the new study determined that there are approximately 90,000 new cases of PD […]

Read More

Can wearing gloves alleviate Parkinson’s symptoms? You may have seen a recent episode of the TODAY show which highlighted...see more a fascinating device developed at Stanford University – a glove that imparts vibration to the fingertips in order to relieve Parkinson’s disease (PD) symptoms. In a small trial, participants wore the glove on each hand for […]

Read More

On Thursday, July 28, the U.S. House of Representatives introduced a bill entitled the NationalPlan to End Parkinson’s Act...see more and on Thursday September 15, a companion bill was introduced in the Senate. This was an exciting moment for the Parkinson’s disease (PD) community, as this Act acknowledged the need for our government to increase its […]

Read More

In an exciting new study, researchers at Brigham and Women’s Hospital in Boston, MA, led by APDA Cotzias Fellowship*...see more awardee Dr. Vikram Khurana, demonstrated a new role for the protein involved in Parkinson’s disease (PD) pathology, alpha-synuclein. In addition to alpha-synuclein interacting with vesicles, or small transport structures within the cell, this new study shows […]

Read More

A new formulation of carbidopa/levodopa 25/100, called DhivyTM, is now available. Manufactured by Avion Pharmaceuticals, its innovation is that...see more it is scored into four sections allowing the pill to be easily cut into four equal parts. Each part contains 6.25 mg of carbidopa and 25 mg of levodopa.  The medication was approved by the US […]

Read More

In 2018, Focused Ultrasound was approved to treat tremors in people with PD.  Now, the FDA has approved expanding...see more the indications of Focused Ultrasound (FUS) for Parkinson’s disease (PD) to also include treatment of bradykinesia (slowness) rigidity (stiffness), and dyskinesias.  Individual ultrasound waves do not contain enough energy to do any damage as they pass […]

Read More

In an exciting new study, researchers at the Graduate Center, City University of New York (CUNY) and the CUNY...see more School of Medicine, led by Dr. Andreas Kottmann, studied levodopa induced dyskinesias (LIDs) and demonstrated that inhibiting a protein called sonic hedgehog (Shh) decreased LIDs in animal models of PD. The study appears today in Communications […]

Read More

May 6, 2021 In an exciting new study, researchers at the APDA Center for Advanced Research at Brigham and...see more Women’s Hospital studied the genetic changes that increase the rate of progression of Parkinson’s disease (PD). Currently, there are many genes that are associated with an increased risk of developing PD. But once a person has […]

Read More

Adamas announced that the Food and Drug Administration (FDA) approved Gocovri for a second indication – as an add-on...see more treatment to carbidopa/levodopa in Parkinson’s disease (PD) patients who are experiencing OFF episodes. Previously, Gocovri was only approved for treatment of Levodopa-induced dyskinesias. You can learn more about managing dyskinesias and OFF episodes in this webinar. […]

Read More